Let’s Talk All Things MoCRA – Is Your Company Prepared?
Webinar | 06.11.24, 1:00 PM EDT - 2:00 PM EDT
Address
Virtual
The FDA will begin to enforce the Modernization of Cosmetics Regulation Act (MoCRA)’s facility and product registration requirements on July 1, 2024. MoCRA has a significant impact on U.S. cosmetic manufacturers and marketers (and suppliers of ingredients). Companies should initiate steps to implement compliant systems now. Is your company prepared? To help make sure you are ready for these new requirements, Crowell & Moring is offering a webinar to discuss MoCRA and describe the key requirements under this law. During this webinar, panelists from Crowell’s Beauty and Wellness team (Robbie Jost, Helen Ogunyanwo, and Julia Carbonetti) and Marcha Isabelle Chaudry (Founder of Equity & Wellness Collaborative) will discuss:
- The statutory obligations under MoCRA
- Who is Responsible for what and when
- What companies should do to comply
Please contact Tricia Wyse with any quesitons.
For more information, please visit these areas: Mass Tort, Product and Consumer Litigation, Product Risk Management, Advertising and Brand Protection
Participants
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26


